Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1161/CIRCOUTCOMES.124.011374 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Effects of national volume-based procurement policy on the usage and expenditure of platinum antineoplastic drugs in China: an interrupted time series study.
Front Pharmacol
August 2025
Department of Pharmacy, The Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China.
Objective: Digestive tract tumors are the common tumors in China. Platinum-based chemotherapy drugs, especially oxaliplatin, play an important role in the treatment of gastrointestinal tumors. Starting from October 2021, the fifth national centralized volume-based procurement (NCVBP) was implemented in China to reduce the price of oxaliplatin.
View Article and Find Full Text PDFInvestigating the impact of edge weight selection on the pig trade network topology.
Epidemics
August 2025
Unit of Veterinary Public Health and Epidemiology, University of Veterinary Medicine Vienna, Veterinaerplatz 1, Vienna, 1210, Vienna, Austria; Complexity Science Hub, Metternichgasse 8, Vienna, 1030, Vienna, Austria. Electronic address:
Traceability of animal movements and robust surveillance are crucial for prevention and control of animal diseases. While network analysis has emerged as a powerful tool for identifying higher-risk holdings through centrality metrics, its effectiveness depends on two methodological choices: (1) edge-weighting schemes (movement frequency vs. animal volume) and (2) centrality metric selection.
View Article and Find Full Text PDFImpact of pooled procurement of medicines on patient adherence and economic burden: evidence from China.
J Glob Health
August 2025
School of Public Health, Peking University, Beijing, China.
Background: Pooled procurement is widely adopted to improve medicine affordability, yet its impact on patients' medicine adherence and economic burden remains underexplored. This study addresses these gaps under China's National Volume-Based Procurement (NVBP) policy.
Methods: Using claims data from Tianjin, China (2017-2020), we conducted a retrospective cohort study of new-users of NVBP antihypertensive medicines before and after policy implementation.
Impact of hospital procedure volume on inpatient outcomes of burns covering 20-50 % of the total body surface receiving skin allograft: An analysis of the US Nationwide Inpatient Sample 2005-2020.
Burns
August 2025
Department of Plastic Surgery, Chung Shan Medical University Hospital, No. 110, Sec., Jianguo N. Rd., South Dist., Taichung City 402306, Taiwan. Electronic address:
Objective: This study examined how hospital procedure volume influences outcomes of burn patients receiving skin allografts.
Methods: Data of adults ≥ 18 years with burns of 20-50 % of the total body surface area who received skin allografts were extracted from the US Nationwide Inpatient Sample (NIS) database 2005-2020. Hospitals were categorized into low- and high-volume based on an annual number of skin allograft procedures, and patients were categorized by type of hospital at which they received treatment.
Pharmaceutical expenditure changes under the volume-based procurement policy: Effects and influencing factors.
PLoS One
August 2025
School of Nursing, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Objectives: To estimate the impact of China's volume-based procurement (VBP) policy on the expenditure of both policy-covered and uncovered drugs, and to identify the elements that contribute to drug expenditure changes under VBP policy.
Methods: Using national drug procurement data of public medical institutions, this study included 25 policy-covered VBP drugs and 99 policy-uncovered alternative drugs as samples, seven "4+7" pilot cities and eight "4+7" expansion provinces as observation regions. Time-varying difference-in-difference (DID) model was applied to quantify policy impact on drug expenditures.